TIDMEKF

RNS Number : 0971A

EKF Diagnostics Holdings PLC

21 March 2017

EKF Diagnostics Holdings plc

("EKF", the "Company")

PDMR dealing

EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.

Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.

The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.

 
     EKF Diagnostics Holdings plc                             www.ekfdiagnostics.com 
     Christopher Mills, Non-Executive                             Tel: 029 2071 0570 
      Chairman 
     Julian Baines, CEO 
     Richard Evans, FD & COO 
 
     N+1 Singer (Nomad & Broker)                                  Tel: 020 7496 3000 
     Alex Price / Shaun Dobson 
      / Alex Laughton-Scott 
 
     Walbrook PR Limited                    Tel: 020 7933 8780 or ekf@walbrookpr.com 
     Paul McManus / Lianne Cawthorne              Mob: 07980 541 893 / 07584 391 303

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
     1        Details of the person discharging managerial 
               responsibilities / person closely associated 
-------  ------------------------------------------------------------------------- 
     a)       Name                           Harwood Capital LLP, as investment 
                                              manager to North Atlantic Smaller 
                                              Companies Investment Trust PLC 
                                              ("NAIT") 
-------  -----------------------------  ------------------------------------------ 
     2        Reason for the notification 
-------  ------------------------------------------------------------------------- 
     a)       Position/status                Christopher Mills, the Company's 
                                              Non-Executive Chairman, is a partner 
                                              and Chief Investment Officer of 
                                              Harwood Capital LLP and a director 
                                              and shareholder in NAIT 
-------  -----------------------------  ------------------------------------------ 
     b)       Initial notification           Initial Notification 
               /Amendment 
-------  -----------------------------  ------------------------------------------ 
     3        Details of the issuer, emission allowance market 
               participant, auction platform, auctioneer or 
               auction monitor 
-------  ------------------------------------------------------------------------- 
     a)       Name                           EKF Diagnostics Holdings plc 
-------  -----------------------------  ------------------------------------------ 
     b)       LEI                            213800DXTF3EAUK1AR05 
-------  -----------------------------  ------------------------------------------ 
     4        Details of the transaction(s): section to be 
               repeated for (i) each type of instrument; (ii) 
               each type of transaction; (iii) each date; and 
               (iv) each place where transactions have been 
               conducted 
-------  ------------------------------------------------------------------------- 
     a)       Description of                 Ordinary shares of 1p each ("Ordinary 
               the financial                  Shares") 
               instrument, type 
               of instrument 
                                              ISIN Code: GB0031509804 
               Identification 
               code 
-------  -----------------------------  ------------------------------------------ 
     b)       Nature of the                  Acquisition of shares 
               transaction 
-------  -----------------------------  ------------------------------------------ 
     c)       Price(s) and volume(s)               Price(s)       Volume(s) 
                                               -------------  -------------- 
                                                    19.5p          8,000,000 
                                               -------------  -------------- 
-------  -----------------------------  ------------------------------------------ 
     d)       Aggregated information         n/a 
 
 
               - Aggregated volume 
 
 
               - Price 
-------  -----------------------------  ------------------------------------------ 
     e)       Date of the transaction        20 March 2017 
-------  -----------------------------  ------------------------------------------ 
     f)       Place of the transaction       London Stock Exchange 
-------  -----------------------------  ------------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXGDXUSDBGRB

(END) Dow Jones Newswires

March 21, 2017 09:47 ET (13:47 GMT)

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ekf Diagnostics Charts.
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ekf Diagnostics Charts.